A tri-specific EGFR/cMet/VEGF antibody demonstrates potent multi-mechanistic activity in preclinical triple-negative breast cancer models

Journal:
Journal of Biological Chemistry
Published:
DOI:
10.1016/j.jbc.2026.113100
Affiliations:
2
Authors:
14
Go to article
Institutions Authors Share
Tavotek Biotherapeutics - China, China
13.000000
13.000000
 0.93
Tavotek Biotherapeutics, United States of America (USA)
1.000000
 0.07